Pharmaceutical Raw Material Sourcing: Managing Quality and Supply Chain Risks
Pharmaceutical Packaging Chemicals: Materials, Safety and Sustainability
Pharmaceutical packaging plays a critical role in protecting medicines from contamination, moisture, oxygen, light and physical damage. Beyond providing a container for finished products, packaging helps preserve drug stability, maintain product integrity and ensure safe handling throughout storage, transportation and administration.
The pharmaceutical packaging industry relies on a wide range of materials and chemical components, including polymers, glass, rubber, adhesives, coatings, inks and protective additives. Each material must be suitable for its intended application because interactions between packaging and pharmaceutical formulations can affect product quality and patient safety.
As regulatory expectations evolve and sustainability becomes a greater industry priority, manufacturers are increasingly evaluating packaging materials based on chemical safety, performance, recyclability and environmental impact.
What Are Pharmaceutical Packaging Chemicals?
Pharmaceutical packaging chemicals are substances used in the manufacture, treatment and performance enhancement of packaging materials for medicines.
They may be incorporated into packaging structures or applied during manufacturing to provide specific properties such as flexibility, strength, barrier protection, printability and chemical resistance.
Important categories include:
Polymer resins and plastic additives
Rubber and elastomer compounds
Adhesives and bonding agents
Printing inks and coatings
Barrier materials
Stabilizers and antioxidants
Lubricants and processing aids
Desiccants and moisture-control materials
These substances are selected according to the packaging format, pharmaceutical formulation, storage conditions and applicable regulatory requirements.
Major Materials Used in Pharmaceutical Packaging
1. Plastic Polymers
Plastics are widely used in pharmaceutical packaging because they are lightweight, versatile and suitable for different container designs.
Common materials include:
High-Density Polyethylene (HDPE): Used in bottles for tablets, capsules and selected pharmaceutical liquids. It provides moisture resistance and mechanical strength.
Polypropylene (PP): Used in containers, closures, medical packaging components and selected pharmaceutical applications. It offers good chemical resistance and heat tolerance.
Polyethylene Terephthalate (PET): Used in selected pharmaceutical bottles and packaging applications where transparency, strength and barrier performance are important.
Polyvinyl Chloride (PVC): Used in certain blister packaging structures, often combined with barrier materials to improve protection against moisture and oxygen.
Cyclic Olefin Polymers (COP) and Cyclic Olefin Copolymers (COC): Used in specialized pharmaceutical packaging, including selected prefilled syringe and injectable drug applications, where dimensional stability and low extractables may be important.
The suitability of a polymer depends on its composition, additives, compatibility with the drug formulation and intended storage conditions.
2. Glass Packaging Materials
Glass remains an important material for pharmaceutical packaging, particularly for injectable medicines and products requiring strong chemical resistance.
Common pharmaceutical glass types include:
Type I borosilicate glass
Type II treated soda-lime glass
Type III soda-lime glass
Glass containers are used in vials, ampoules, bottles and other pharmaceutical packaging formats.
Type I borosilicate glass is commonly selected for products requiring high hydrolytic resistance. However, glass selection must consider the formulation, manufacturing process and intended application.
3. Rubber and Elastomer Components
Rubber and elastomer materials are commonly used in closures and sealing systems.
Applications include:
Injectable vial stoppers
Prefilled syringe components
Bottle closures
Sealing rings
Flexible container components
Elastomer formulations may contain polymers, curing agents, fillers, pigments, lubricants and other additives.
These materials must be evaluated for their chemical compatibility and potential to release substances into pharmaceutical products.
4. Adhesives, Inks and Coatings
Adhesives and coatings are used in labels, cartons, flexible packaging and multilayer structures.
Their functions include:
Bonding different packaging layers
Providing print adhesion
Protecting printed information
Improving surface resistance
Supporting tamper-evident features
Enhancing packaging appearance
Packaging inks and adhesives require particular attention because certain chemical constituents may migrate through packaging layers or interact with the packaged product.
Important Chemicals and Additives Used in Packaging
Packaging performance depends not only on the base material but also on the additives incorporated during manufacturing.
Plasticizers
Plasticizers improve flexibility and processability in selected polymer systems.
Their use must be carefully controlled because certain plasticizers may migrate from packaging materials under particular conditions.
Antioxidants and Stabilizers
Antioxidants help protect polymers against oxidative degradation during processing and storage.
Stabilizers may also improve resistance to heat, light and environmental exposure.
The selected additive system must be appropriate for the packaging material and must not compromise pharmaceutical product quality.
Lubricants and Processing Aids
Lubricants and processing aids support manufacturing operations by reducing friction, improving material flow and helping achieve consistent production.
Their suitability depends on the manufacturing process and the potential for chemical transfer or residue formation.
Desiccants
Desiccants help control moisture inside pharmaceutical packaging.
Common materials include silica gel and molecular sieves. They are frequently used in bottles containing moisture-sensitive tablets and capsules.
Desiccants help maintain suitable internal humidity conditions but must be selected and packaged to prevent direct contact or contamination of the medicine.
Barrier Coatings
Barrier coatings are used to improve packaging protection against moisture, oxygen, light or other environmental factors.
Examples include selected polymer coatings, metallized structures and aluminium-based barrier layers.
These materials can be particularly important for pharmaceutical products with specific environmental sensitivity.
Applications Across Pharmaceutical Packaging Formats
Blister Packaging
Blister packaging is commonly used for tablets and capsules.
It generally combines a formed plastic cavity with a lidding material, often aluminium foil.
PVC, PET and other polymers may be used in blister structures, while high-barrier materials such as aluminium-based laminates provide additional protection where required.
Important considerations include:
Moisture barrier performance
Oxygen protection
Heat-sealing compatibility
Mechanical strength
Product stability
Packaging integrity
Pharmaceutical Bottles
Plastic and glass bottles are widely used for tablets, capsules, powders and liquid medicines.
HDPE and PET are common plastic options, while glass is selected for products requiring particular chemical or barrier characteristics.
Closures, liners and induction seals also contribute to packaging integrity.
Injectable and Parenteral Packaging
Injectable medicines require packaging systems that meet demanding quality and safety requirements.
Common formats include glass vials, ampoules, prefilled syringes and elastomeric closures.
Packaging materials must be evaluated for compatibility, extractables and leachables, sterility-related requirements and container-closure integrity.
Flexible Pharmaceutical Packaging
Flexible packaging materials are used in selected pharmaceutical products, sachets, pouches and protective structures.
The design must provide suitable protection while maintaining the required sealing and mechanical properties.
Chemical Safety: Extractables and Leachables
One of the most important considerations in pharmaceutical packaging is the potential migration of chemical substances from packaging materials into the drug product.
Two terms are particularly important:
Extractables are chemical substances that can be extracted from packaging or delivery-system materials under specified laboratory conditions.
Leachables are chemical substances that migrate from packaging materials into a pharmaceutical product under actual or simulated conditions of use and storage.
Potential sources include:
Polymer additives
Plasticizers
Antioxidants
Adhesives
Printing inks
Rubber components
Coatings
Processing residues
These substances may affect product stability, purity, potency or patient safety.
ICH Q3E provides a framework for assessing and controlling leachable impurities in new drug products, including relevant packaging and delivery-system components. Its approach is based on risk assessment and patient protection.
Source: FDA – ICH Q3E Guideline for Extractables and Leachables
Why Extractables and Leachables Testing Matters
Testing helps manufacturers understand which chemical substances may be released from packaging materials and whether their presence could create a risk.
The assessment may involve:
Material characterization
Extractables studies
Leachables studies
Analytical method development
Toxicological evaluation
Stability testing
Risk assessment
USP General Chapters <1663> and <1664> provide frameworks for assessing extractables and leachables associated with pharmaceutical packaging and delivery systems.
Source: USP – Assessment of Extractables
Regulatory Requirements for Pharmaceutical Packaging
Pharmaceutical packaging materials must meet applicable regulatory and quality requirements in the markets where the medicines are manufactured or sold.
US FDA Requirements
The FDA provides guidance on container-closure systems used for human drugs and biological products.
Its guidance addresses the information manufacturers should provide to demonstrate that packaging components are suitable for their intended use.
Under 21 CFR 211.94, drug product containers and closures must not be reactive, additive or absorptive in ways that could adversely affect the safety, identity, strength, quality or purity of the drug product.
Source: FDA – Container Closure Systems for Packaging Human Drugs and Biologics
European Medicines Agency Requirements
The European Medicines Agency provides guidance on plastic immediate packaging materials for medicinal products.
The guidance discusses extraction studies, migration studies, sorption and toxicological information relevant to packaging suitability.
Manufacturers may need to demonstrate that substances migrating from packaging do not create unacceptable risks or adversely affect product quality.
Source: EMA – Guideline on Plastic Immediate Packaging Materials
Pharmaceutical Packaging Standards
Pharmacopoeial standards also support packaging material qualification.
Relevant USP chapters include:
USP <661.1>: Plastic materials of construction
USP <661.2>: Plastic packaging systems for pharmaceutical use
USP <1663>: Assessment of extractables
USP <1664>: Assessment of drug product leachables
USP <1031>: Biocompatibility of pharmaceutical packaging systems
These chapters provide technical frameworks for assessing packaging materials and their suitability for pharmaceutical applications.
Sustainability in Pharmaceutical Packaging
Sustainability is becoming an increasingly important consideration for pharmaceutical packaging manufacturers.
Traditional packaging structures often combine several materials to achieve the necessary barrier and protection properties. Although these structures can provide effective product protection, they may be difficult to separate and recycle.
Manufacturers are therefore exploring ways to reduce environmental impact without compromising medicine quality or patient safety.
1. Recyclable Packaging Materials
The use of recyclable materials, including selected HDPE, PET and PP packaging structures, can support waste reduction where suitable collection and recycling infrastructure exists.
However, pharmaceutical packaging must first meet product-specific safety and performance requirements.
A material should not be selected solely because it is recyclable if it cannot provide the necessary protection for the medicine.
2. Lightweight Packaging
Reducing packaging weight can help lower material consumption and transportation-related emissions.
Examples include optimizing bottle wall thickness, reducing unnecessary secondary packaging and improving packaging design.
Any reduction must be validated to ensure that packaging strength, sealing performance and product protection remain acceptable.
3. Recycled Content
Recycled polymers may offer opportunities to reduce demand for virgin materials.
However, the use of recycled content in pharmaceutical packaging requires careful evaluation of material purity, contamination risks, traceability and regulatory suitability.
The requirements can differ significantly between secondary packaging and packaging that directly contacts the medicine.
4. Alternative Packaging Materials
Manufacturers are evaluating alternative materials and packaging structures, including paper-based solutions, bio-based polymers and other lower-impact designs.
These alternatives must be assessed for:
Moisture and oxygen barrier performance
Chemical compatibility
Mechanical strength
Sterilization compatibility, where applicable
Extractables and leachables
Shelf-life performance
End-of-life management
Sustainability improvements must be demonstrated through appropriate product and environmental assessments rather than assumed from material labels alone.
EU Packaging and Packaging Waste Regulation
The European Union's Packaging and Packaging Waste Regulation (PPWR), Regulation (EU) 2025/40, entered into force on 11 February 2025 and generally applies from 12 August 2026.
The regulation introduces requirements covering packaging sustainability, substances of concern, recyclability, packaging waste and related circular-economy objectives.
However, pharmaceutical packaging has specific provisions and derogations. Manufacturers should assess the exact requirements applicable to their packaging type and product rather than assuming that every general packaging obligation applies in the same way to medicinal products.
Source: European Commission – Packaging and Packaging Waste Regulation
Procurement Considerations for Pharmaceutical Packaging Materials
For pharmaceutical manufacturers, packaging material procurement requires a combination of technical, regulatory and commercial evaluation.
Important factors include:
Material specifications: Confirm polymer type, grade, composition and relevant physical and chemical characteristics.
Regulatory documentation: Request applicable compliance statements, technical data and supporting quality documentation.
Extractables and leachables data: Review available studies and determine whether additional product-specific assessments are required.
Material compatibility: Evaluate the interaction between the packaging system and the pharmaceutical formulation.
Packaging integrity: Confirm that containers, closures and seals provide appropriate protection throughout the product lifecycle.
Supplier qualification: Assess manufacturing controls, quality systems, traceability and change-control procedures.
Sustainability information: Request credible information about recycled content, recyclability, material reduction and environmental performance.
Supply continuity: Review supplier capacity, lead times, batch consistency and availability of alternative sources.
Challenges Facing Pharmaceutical Packaging Manufacturers
The industry faces several challenges as it balances product protection, chemical safety and environmental objectives.
Maintaining Product Stability
Packaging materials must protect medicines from environmental conditions and prevent unwanted interactions throughout storage and transportation.
Controlling Chemical Migration
Manufacturers must identify and evaluate potential extractables and leachables to ensure that packaging does not compromise product quality or patient safety.
Balancing Sustainability With Safety
Recyclable or alternative materials may have different barrier properties, processing characteristics and impurity profiles. Changes therefore require technical assessment and, where necessary, regulatory evaluation.
Managing Complex Packaging Structures
Multilayer packaging can improve performance but may introduce challenges related to material separation, recycling and chemical characterization.
Maintaining Supplier Consistency
Changes in polymer formulations, additives, manufacturing processes or packaging components can affect product performance. Strong supplier qualification and change-control systems are essential.
Future Outlook for Pharmaceutical Packaging Chemicals
The future of pharmaceutical packaging will increasingly depend on materials that combine reliable product protection, chemical safety and improved environmental performance.
Innovations in polymer technology, barrier coatings, material characterization and packaging design are creating opportunities for manufacturers and chemical suppliers.
At the same time, regulatory attention to extractables and leachables, packaging waste and material sustainability is increasing the importance of technical documentation and lifecycle assessment.
For pharmaceutical manufacturers, the priority will remain unchanged: packaging must protect the medicine and the patient. Sustainability improvements will need to demonstrate that they can achieve these objectives while reducing unnecessary material use and environmental impact.
What Buyers Should Look for in a Pharmaceutical Packaging Supplier
Selecting a packaging material supplier requires evaluating the complete material system rather than considering only the base polymer or packaging price.
Buyers should prioritize suppliers that can provide:
Consistent pharmaceutical-grade materials
Detailed technical specifications
Relevant chemical safety documentation
Extractables and leachables information
Material compatibility data
Manufacturing and quality-system information
Change-control and traceability procedures
Verified sustainability information
A supplier that combines technical support, reliable documentation and consistent material quality can help pharmaceutical manufacturers manage packaging risks and meet evolving industry expectations.
Sources
Anthracite
Found this useful?
